RE:RE:MM’s Napkin Math Gibber jabber ?
You haven't explained the basis for your claim
"At 90 patients Spectral was/is worth $3 per share."
If you're saying it should be trading at $3 today, pre-approval , then you need to be clear about that, and explain what the investing community is missing and how.
Your final answer is probably wrong and unfortunately I can't give you partial marks since you don't show your work
Nor have you indicated USD vs CAD $ ;)
You'll be permitted to take a makeup test
MM